The Readout Loud
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
126
272: Vivek's star turn, leaky drug data, & biot...
We discuss how Vivek Ramaswamy, fresh off his hea…
29 min
127
271: Racing for gene therapy, a pioneering appr...
Our colleague Jason Mast joins us to explain how …
34 min
128
270: Your guide to Wegovy’s blockbuster heart s...
In the wake of a massively important clinical tri…
32 min
129
269: Biotech layoffs, eye drug drama, & gene th...
First, we discuss how some recent layoffs and a r…
37 min
130
268: Biogen's sticky situation, Wegovy's risks,...
First, we discuss why Wall Street was less than c…
36 min
131
267: BridgeBio's big week, Lilly's Alzheimer's ...
Neil Kumar, CEO of BridgeBio, joins us to talk ab…
35 min
132
266: Wegovy in the brain, pivotal Alzheimer's d...
Our colleague Megan Molteni joins us to explain t…
32 min
133
265: Novavax's CEO promises a turnaround & how ...
Our colleague Elaine Chen joins us to explain how…
35 min
134
264: Messy PBM conflicts, debatable vaccines, &...
Our colleague Bob Herman joins us to explain his …
36 min
135
263: Biogen's messy board, Laronde's data probl...
Our colleague Allison DeAngelis joins us to share…
39 min
136
262: Merck v. USA, the best of ASCO, and Leqemb...
STAT Washington correspondent Rachel Cohrs joins …
29 min
137
261: Fake medical devices, real cancer drugs, &...
Our colleague Lizzy Lawrence joins us to explain …
31 min
138
260: ChatGPT in medicine, a boom in weight loss...
As hospitals and health care companies are racing…
31 min
139
259: The FTC v. Amgen, Sarepta's future, & Gala...
Jared Holz, biotech strategist at Mizuho Securiti…
40 min
140
258: Pharma vs. PBMs, Sarepta at the FDA, & a b...
We discuss a Senate hearing that put major pharma…
31 min
141
257: Lilly's Alzheimer's success, a milestone F...
Eli Lilly’s investigational medicine for Alzheime…
34 min
142
256: Explaining the E.U.'s pharma overhaul, Lil...
Andrew Joseph, STAT's Europe correspondent, joins…
28 min
143
255: Sarepta's pivotal moment, biotech's big we...
Our colleague Helen Branswell joins us to explain…
39 min
144
254: The legal battle over abortion, an FDA 'bu...
Jeremy Levin, CEO of Ovid Therapeutics, joins us …
40 min
145
253: Illumina’s boardroom intrigue, the next bi...
Our colleague Matthew Herper joins us for a deep …
36 min
146
252: Biotech's monkey shortage, the broken gene...
We explain how biotech is affected by a bizarre s…
36 min
147
251: Bancel v. Bernie, Sarepta's FDA runaround,...
We discuss the theatrical merits and actual impli…
34 min
148
250: SVB's long biotech shadow, pushy AI algori...
STAT reporter Bob Herman joins us to explain how …
35 min
149
249: Robert Califf on how drugs get approved, p...
FDA Commissioner Robert Califf joins to discuss h…
38 min
150
248: The next CRISPR fight, cheaper insulin, & ...
Our colleague Allison DeAngelis joins us to expla…
28 min